Skip to content

Effectiveness and Safety of Acupuncture for Cancer-Related Hiccups: A Systematic Review and Meta-Analysis

Guo et al. · Frontiers in Neurology · 2024

🔬Systematic Review with Meta-Analysis👥n = 580 patients⚠️High risk of bias
🎯

OBJECTIVE

To assess the efficacy and safety of acupuncture in the treatment of cancer-related hiccups

👥

WHO

Oncology patients aged 25-78 years with hiccups caused by cancer or its treatments

⏱️

DURATION

9 studies analyzed through July 2023

📍

POINTS

Zusanli (ST-36) and Neiguan (PC-6) were the most commonly used

🔬 Study Design

580participants
randomization

Acupuncture

n=293

Manual acupuncture, electroacupuncture, or auricular acupuncture

Control

n=287

Medications (baclofen, metoclopramide)

⏱️ Duration: Variable across included studies

📊 Results in numbers

0

Superior efficacy rate of acupuncture

-8.71 min

Faster onset of action

0

Sleep improvement

0

Feeding improvement

0

Appetite improvement

📊 Outcome Comparison

Relative efficacy rate

Acupuncture
1.83
Medications
1
💬 What does this mean for you?

This study examined whether acupuncture can help cancer patients who suffer from hiccups. The results showed that acupuncture was more effective than standard medications, improving sleep, appetite, and quality of life, with few side effects.

📝

Article summary

Plain-language narrative summary

This systematic review and meta-analysis investigated the efficacy and safety of acupuncture in the treatment of cancer-related hiccups, a symptom that affects 15-40% of oncology patients and can have a significant impact on quality of life. The researchers conducted a comprehensive search across eight databases, identifying nine randomized clinical trials that enrolled 580 patients. Cancer-related hiccups may result from central or peripheral organic lesions, oncologic treatments, electrolyte disturbances, or acid-base imbalances, causing not only involuntary diaphragmatic spasms but also insomnia, fatigue, malnutrition, depression, and irritability. The methodology followed the PRISMA 2020 guidelines and included frequency analysis of acupoint use.

The types of acupuncture studied were manual acupuncture, electroacupuncture, auricular acupuncture, and pressure needling. Control arms received pharmacologic treatments such as oral baclofen and metoclopramide injections. The meta-analysis results demonstrated that acupuncture was significantly superior to pharmacologic treatments in efficacy rate, with a relative risk of 1.83 (95% CI [1.53, 2.20], p < 0.001). Acupuncture also showed a faster onset of action, with a mean difference of -8.71 minutes compared with medications.

With respect to quality of life, acupuncture provided significant improvements in sleep, feeding, and appetite scores, with mean differences of 0.68, 0.68, and 0.66, respectively. Frequency analysis revealed that the points Zusanli (ST-36) and Neiguan (PC-6) were the most commonly used, present in seven of the nine studies. ST-36 belongs to the stomach meridian and PC-6 to the pericardium meridian, traditionally used to regulate stomach and spleen qi. Subgroup analysis showed that electroacupuncture was more effective than manual acupuncture, although with greater heterogeneity.

Regarding safety, acupuncture demonstrated a favorable profile, with only one patient reporting mild pain among 158 treated, and no serious adverse events were observed. Proposed mechanisms include improved blood flow to the hypothalamus, bidirectional regulation of gastrointestinal motility, influence on the neuroendocrine system through stimulation of nerve endings at acupuncture points, promoting production of neurotransmitters such as norepinephrine, serotonin, and gamma-aminobutyric acid. Acupuncture may also activate the cerebral cortex and suppress abnormal vagal nerve excitation. Despite the promising results, all important limitations must be considered.

All nine included studies had a high risk of bias, mainly due to lack of blinding of participants and clinicians, and problems with random sequence generation. Allocation concealment was inadequately reported in most studies, raising concerns about subjective selection. Significant heterogeneity persisted even after subgroup analyses and meta-regression, possibly due to differences in tumor types, intervention frequencies, and other design aspects. The small sample size and limited methodological quality of the included studies reduce the reliability of the results.

The clinical implications suggest that acupuncture may be a valuable alternative to pharmacologic treatments for cancer-related hiccups, especially given that conventional medications often cause adverse effects such as dizziness and excessive sedation in patients already debilitated by multiple therapies. Future research should focus on high-quality clinical trials, following the progression from exploratory to explanatory and confirmatory research, in addition to establishing unified diagnostic standards and clinical practice guidelines for cancer-related hiccups.

Strengths

  • 1Comprehensive search across eight databases
  • 2Followed PRISMA 2020 guidelines
  • 3Acupoint frequency analysis provides practical insights
  • 4First updated meta-analysis since 2012
  • 5Subgroup analysis by acupuncture type
⚠️

Limitations

  • 1High risk of bias in all included studies
  • 2Significant heterogeneity across studies
  • 3Small samples in individual studies
  • 4Lack of adequate sham acupuncture use
  • 5Methodologic problems in blinding and allocation
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Persistent or intractable hiccups in oncology patients are an under-recognized symptom that directly interferes with food intake, sleep quality, and emotional state — dimensions that compromise treatment tolerance and functional prognosis. With prevalence estimated at 15-40% in this population, the symptom frequently appears in patients already burdened by multiple medications, making the adverse effects of baclofen and metoclopramide — sedation, dizziness, cognitive impairment — particularly costly. The Guo et al. meta-analysis provides the oncologist and the acupuncturist physician with a quantitative basis for including acupuncture in early therapeutic discussions, not as a last resort but as a first- or second-line option. The relative risk of 1.83 compared with standard pharmacotherapy, combined with the exceptional documented safety profile, justifies formal integration of acupuncture into supportive oncology protocols, especially at services that already have physicians trained in the technique.

Notable Findings

The most clinically meaningful finding is not just the statistical superiority of acupuncture, but the 8.71-minute faster onset of action compared with pharmacotherapy — a metric with real weight at the bedside, where intractable hiccups are a source of acute distress. Equally relevant is the documented improvement in the three functional domains evaluated — sleep, feeding, and appetite — whose scores followed parallel and consistent trajectories. The acupoint frequency analysis reveals that ST-36 and PC-6 appear in seven of the nine studies, a convergence that is not accidental: both engage neurovegetative pathways with demonstrated action on gastrointestinal motility and vagal modulation. Electroacupuncture showed superiority over manual acupuncture in the subgroup analysis, suggesting that the electrical stimulation parameter potentiates the proposed neuroendocrine mechanisms — release of serotonin, norepinephrine, and GABA — with direct relevance for the choice of technical modality in the hospital setting.

From My Experience

In my practice at the HC-FMUSP Pain Center, I have been treating persistent hiccups in oncology contexts for decades, and the response pattern I observe is consistent with what this work quantifies. In general, I see relief as early as the first or second session when we use electroacupuncture at ST-36 and PC-6, often adding ST-37 and CV-12 to reinforce gastric regulation. I typically structure an initial cycle of six to eight sessions on alternate days for persistent cases, with reassessment of frequency based on response. The patient profile that responds best, in my experience, is one with hiccups of predominantly functional-autonomic origin — without massive diaphragmatic compression by tumor — generally induced by chemotherapy or electrolyte disturbance. When there is structural phrenic compression, results are more modest and acupuncture enters as adjunctive symptomatic support rather than the main therapeutic axis. Combination with diaphragmatic relaxation techniques and postural adjustment, guided jointly with physical therapy, has potentiated the results I see routinely — and this study reinforces that this integrative approach deserves formal protocolization.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Frontiers in Neurology · 2024

DOI: 10.3389/fneur.2024.1480656

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.